The Influenced factors of the Efficacy and Anemia Adverse Effects Induced by Pegylated Interferon Alpha plus Ribavirin in Chronic Hepatitis C
碩士 === 中山醫學大學 === 醫學研究所 === 100 === Background： The World Health Organization estimates that 3% of world’s population is infected with the Hepatitis C virus（HCV）and there are 300,000 people with HCV infection in Taiwan. The current standard of therapy is a combination of pegylated interferon and rib...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | zh-TW |
| Published: |
2012
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/47661791514336302267 |